Navigation Links
ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
Date:12/3/2008

SAN FRANCISCO, Dec. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) will host its annual High School Student Symposium at the San Francisco Marriott on Thursday, December 4, 2008, beginning at 8:00 a.m. PST. The symposium, which encourages an interest in hematology, the biological sciences, and medical research, is held in conjunction with the Society's 50th Annual Meeting. This year, students will have the opportunity to explore research on sickle cell disease, an inherited blood disorder that distorts the shape of red blood cells, causing severe pain in patients who have the disease.

"Part of ASH's mission is to help train the next generation of biomedical scientists and clinicians, and the High School Symposium plays an important role in that endeavor, showing these young students that hematology is an exciting field that critically affects human health," said Scott D. Gitlin, MD, Chair of ASH's Committee on Training Programs, which organized the event.

Students from four local high schools, including Abraham Lincoln High School, Thurgood Marshall Academic High School, Wallenberg High School, and Galileo Academy High School, will participate in a series of activities related to sickle cell disease during the half-day symposium. Each student will receive a worksheet to gather data related to the presentations. Teachers will later use the worksheet to facilitate classroom discussions. In addition, small breakout sessions will provide the students with hands-on demonstrations and scientific techniques related to sickle cell disease and biomedical research.

After a kick-off breakfast, two physicians from the Children's Hospital and Research Center at Oakland will give presentations. Keith Quirolo, MD, will give a lecture on the diagnosis and clinical manifestations of sickle cell disease followed by Carolyn Hoppe, MD, who will discuss treatment options. Students will also have the opportunity to hear about real-life experiences from young people living with sickle cell disease.

In addition, ASH will sponsor a poster contest for symposium participants. Students, in teams, can conduct research on sickle cell disease and present their findings in a poster and oral presentation. ASH symposium speakers and volunteers will judge the posters, awarding the top three groups with prizes of $1,500, $1,000, and $750 to be provided to the winning teams' science departments.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood disorders including risk factors, preventive measures, and treatment options. A cornerstone of this public awareness campaign is a new documentary by award-winning filmmaker Joseph Lovett called "Blood Detectives," which will air on the Discovery Health cable network on December 19, 2008, at 7:00 p.m. ET/PT and again at 12:00 midnight. The show focuses on hematologists as they work to unravel medical mysteries and save lives.


'/>"/>
SOURCE American Society of Hematology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
2. Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judges Pen as Vendors Vie for Approval
3. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
4. Epilepsy Drug Holds Promise as Treatment for Alcoholism
5. Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast
6. Alzheimers Foundation of America Holds Fifth Annual National Memory Screening Day
7. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
8. University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome
9. Go Red For Women Holds Nationwide Casting Call to Find the Heart of Go Red
10. Fruit fly phlebotomy holds neuroscience promise
11. American Association for Dental Research holds 37th annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... management skills and infrastructure. Most providers, however, are unsure how to move forward, ... Ascend to define a path forward tailored to an organization’s specific needs. ...
(Date:6/24/2016)... ... 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located to ... vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat center ... as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. The ...
(Date:6/23/2016)... ... June 23, 2016 , ... An article published June 8 on ... head and neck cancer in individuals with unhealthy oral hygiene habits. The article goes ... whether they had gum disease, brushed their teeth on a daily basis, wore dentures ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... today announced SentinelSecure™, its containerized mobile security software, is featured in the current ... online community that identifies leading companies with innovative technology solutions and features them ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
(Date:6/23/2016)... Tenn. , June 23, 2016 /PRNewswire/ ... automating, integrating and transforming the patient payment ... of several innovative new products and services ... of its revenue cycle offerings. These award-winning ... more efficient workflows, remain compliant in an ...
Breaking Medicine Technology: